Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency

Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the treatment. In a previous study, we have detected high...

Полное описание

Библиографические подробности

Главные авторы:	N. Yu. Sviridenko, E. G. Bessmertnaya, I. M. Belovalova, M. S. Sheremeta, D. M. Babaeva, N. M. Malysheva, E. A. Troshina, G. A. Melnichenko
Формат:	Artigo
Язык:	Russo
Опубликовано:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-11-01
Серии:	Медицинская иммунология
Предметы:	graves’ disease endocrine ophthalmopathy cytokines antibodies glucocorticoids
Online-ссылка:	https://www.mimmun.ru/mimmun/article/view/2514
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!